Johnson & Johnson (JNJ) — The Transparent Read
67/100Cautiously Bullish$258.51 · uptrend
This is a healthy uptrend hitting a logical pause point. The long-term and medium-term trend signals are unambiguously constructive, momentum is positive, and the macro base rate leans favorably over a 90-day horizon. But with RSI at 75 and price kissing resistance at $258.58, I'd expect either a breakout that needs volume to confirm, or a near-term cooldown. My lean is cautiously bullish on the 90-day view, while respecting that chasing it right at resistance with an overbought RSI invites short-term whipsaw. Patience for a clean breakout above $258.58 or a pullback toward the 50-day looks smarter than buying the spike.
JNJ key levels
Show Your Work — every point in JNJ's score
The score starts at 50, then each signal below adds or subtracts points. No black box.
| Signal | Type | Points |
|---|---|---|
| Above 200-day MA Price is above its 200-day average — long-term trend is up. | technical | +8 |
| Above 50-day MA Trading above the 50-day average — medium-term momentum is positive. | technical | +5 |
| Golden cross 50-day average is above the 200-day (golden cross). | technical | +4 |
| RSI overbought RSI is 75 — overbought, near-term pullback risk. | technical | -6 |
| MACD positive MACD is above its signal line — momentum is building. | technical | +5 |
| Near resistance Pressing against resistance around $258.58. | technical | -4 |
| Macro regime base rate In 38 past periods like today (Rising inflation + Steady Fed), this stock was higher 90d later 74% of the time (median +5.8%). Historically favorable. | macro | +4.74 |
Macro regime base rate
Today's regime: Rising inflation + Steady Fed
In 38 past periods that looked like today, JNJ was higher 90 days later 74% of the time (median move 5.8%). Confidence: high.
The read
JNJ Rides a Strong Uptrend Into Resistance — Bullish, But Stretched
Bull case. JNJ is firing on the trend cylinders: price at $258.51 sits comfortably above both its 50-day ($230.45) and 200-day ($215.74) moving averages, with a confirmed golden cross signaling structural strength. MACD histogram is positive at +2.35, telling us momentum is still building. The macro backdrop is a tailwind too — in 38 analogous Rising Inflation + Steady Fed periods, JNJ was higher 90 days later 74% of the time with a median gain of +5.8% (high confidence). The composite score of 66.7 lands this squarely in Cautiously Bullish territory.
Bear case. The near-term picture flashes caution. RSI at 75 is firmly overbought, which historically raises pullback risk after a hot run. The stock is also pressing right up against resistance at $258.58 — essentially at the ceiling, with last price at $258.51. A rejection here is a real possibility, and overbought conditions can resolve through either a stall or a pullback toward the 50-day MA before the next leg.
What would change my mind. A decisive close back below the 50-day MA at $230.45 would break the medium-term momentum structure and flip my cautiously bullish stance to neutral or defensive. Conversely, a confirmed breakout and close above resistance at $258.58 would clear the path and strengthen the bull thesis.
JNJ — frequently asked
Is JNJ a buy according to Tallyread?
Tallyread does not give buy or sell recommendations. It shows a transparent 67/100 read for Johnson & Johnson (JNJ), conditioned on today's macro regime, with every scoring input itemized so you can judge for yourself. This is not financial advice.
How is JNJ's Tallyread score calculated?
The 67/100 score starts at 50, then adds and subtracts named technical and macro signals — each shown with its point value and a one-line reason in the "Show Your Work" table on this page. Nothing is hidden in a black box.
How does today's Fed-and-inflation regime affect JNJ?
In 38 past periods whose macro regime matched today's (Rising inflation + Steady Fed), JNJ was higher 90 days later 74% of the time, with a median move of 5.8%. Confidence: high.
Want a fresh read on JNJ with the live chart and macro tape?
Run a live JNJ read →Last analyzed 2026-06-30 · Data source: tiingo. See the public scorecard and methodology.
This is a historical and technical read for informational and educational purposes only — not financial advice, and not a recommendation to buy or sell JNJ. Markets are uncertain; do your own research.